Certified by Founder Lodge
Matchpoint Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 17 ,2022 | Series A | $100,000,000 |
Access Industries
Sanofi
Atlas Venture
Vertex Ventures HC
Digitalis Ventures
Alexandria Real Estate Equities, Inc.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)